Melatonin alleviates vascular endothelial cell damage by regulating an autophagy‐apoptosis axis in Kawasaki disease

Abstract

Objectives: Melatonin has been reported to be an appropriate candidate for mitigating various cardiovascular injuries, owing to its versatility. This study aimed to explore the role of melatonin in Kawasaki disease (KD)-associated vasculitis and its underlying mechanisms. Material and Methods: The role of melatonin was evaluated in human coronary artery endothelial cells (HCAECs), peripheral blood mononuclear cells from KD patients, human THP1 cell line in vitro, and a Candida albicans water-soluble fraction (CAWS)-induced KD mouse model in vivo. Cell proliferation assay, cell apoptosis assay, cell co-culture, RNA extraction, RNA sequencing, reverse transcription quantitative PCR, enzyme-linked immunosorbent assay (ELISA), transwell assay, western blot, dual-luciferase reporter assay, and autophagic flux assay were performed to investigate the function and regulatory mechanisms of melatonin in vitro, while haematoxylin and eosin staining, Verhoeff's van Gieson staining, ELISA, and immunohistochemical analysis were performed to detect the effect of melatonin in vivo. Results: Melatonin suppressed cell apoptosis directly reduced the expression of endothelial cell damage markers in HCAECs, and alleviated vasculitis in the CAWSinduced KD mouse model. Mechanistically, melatonin promoted autophagy by activating the melatonin/ melatonin receptor (MT)/cAMP-response element binding protein (CREB) pathway and upregulating the expression of autophagy-related gene-3, thereby suppressing cell apoptosis in an autophagy-dependent manner. Additionally, melatonin decreased the production of pro-inflammatory cytokines in macrophages and indirectly reduced the immunopathological damage of HCAECs.Conclusions: This study revealed that melatonin protects vascular endothelial cells in KD, by suppressing cell apoptosis in an autophagy-dependent manner and reducing the immunopathological damage mediated by macrophages.

Traditional Chinese medicine and its active substances reduce vascular injury in diabetes via regulating autophagic activity

“…In addition, autophagy can also regulate vascular permeability via adjusting the apoptosis and inflammatory response of endothelial cells. As shown by Zheng YZ et al's research ( Zheng et al, 2022 ), melatonin directly reduced the expression of endothelial cell injury markers in HCAECs, thereby alleviating the vascular inflammation induced by candida albicans water-soluble components (CAWS) in a Kawasaki disease mouse model. Mechanistically, melatonin promotes autophagy by activating the melatonin/melatonin receptor (MT)/cAMP response element binding protein (CREB) pathway and upregulating AGT3 expression, so as to inhibit cell apoptosis in an autophagy-dependent manner.…”

Potential effects of shift work on skin autoimmune diseases

“…Undoubtedly, sleep is impaired in patients with systemic autoimmune diseases ( 178 ). Moreover, they show disturbances in 24 h rhythms of their stress systems ( 179 , 180 ), cardiovascular functions ( 181 ), and melatonin ( 182 – 185 ). These changes may be the consequence rather than the cause of the autoimmune disease, as disease symptoms such as pain, itch, respiratory or gastrointestinal dysfunctions can heavily interfere with a regular sleep-wake behavior ( 186 ).…”

Natural-Product-Mediated Autophagy in the Treatment of Various Liver Diseases

“…Many transcription factors such as p53 protein, BH3 (BCL-2 homology 3)-only proteins, Ser/Thr kinases and oncogenes are the common upstream signals of apoptosis and autophagy. They usually cross-regulate each other, yet responsible mechanisms of interplay between them have been partially but not fully elucidated in different diseases [ 52 , 53 ]. As described earlier, a panoply of natural products exert either pro- or anti-HCC properties in an autophagy-dependent manner, and regulations on autophagy, apoptosis or ACD exist intricately in this process.…”